Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 286

1.

Potential roles of HDAC inhibitors in mitigating ischemia-induced brain damage and facilitating endogenous regeneration and recovery.

Fessler EB, Chibane FL, Wang Z, Chuang DM.

Curr Pharm Des. 2013;19(28):5105-20. Review.

PMID:
23448466
2.

Histone deacetylase inhibitors exhibit anti-inflammatory and neuroprotective effects in a rat permanent ischemic model of stroke: multiple mechanisms of action.

Kim HJ, Rowe M, Ren M, Hong JS, Chen PS, Chuang DM.

J Pharmacol Exp Ther. 2007 Jun;321(3):892-901. Epub 2007 Mar 19.

3.

Targeted acetylation of NF-kappaB/RelA and histones by epigenetic drugs reduces post-ischemic brain injury in mice with an extended therapeutic window.

Lanzillotta A, Pignataro G, Branca C, Cuomo O, Sarnico I, Benarese M, Annunziato L, Spano P, Pizzi M.

Neurobiol Dis. 2013 Jan;49:177-89. doi: 10.1016/j.nbd.2012.08.018. Epub 2012 Aug 30.

PMID:
22971966
4.

Targeting histone acetylation for neuroprotection.

Contestabile A.

Curr Pharm Des. 2013;19(28):5017-8. No abstract available.

PMID:
23448467
5.

Histone deacetylase inhibition activates transcription factor Nrf2 and protects against cerebral ischemic damage.

Wang B, Zhu X, Kim Y, Li J, Huang S, Saleem S, Li RC, Xu Y, Dore S, Cao W.

Free Radic Biol Med. 2012 Mar 1;52(5):928-36. doi: 10.1016/j.freeradbiomed.2011.12.006. Epub 2011 Dec 17.

PMID:
22226832
6.

Deciphering the neuroprotective mechanisms of Bu-yang Huan-wu decoction by an integrative neurofunctional and genomic approach in ischemic stroke mice.

Wang HW, Liou KT, Wang YH, Lu CK, Lin YL, Lee IJ, Huang ST, Tsai YH, Cheng YC, Lin HJ, Shen YC.

J Ethnopharmacol. 2011 Oct 31;138(1):22-33. doi: 10.1016/j.jep.2011.06.033. Epub 2011 Jul 8.

PMID:
21784143
7.

Injury and repair mechanisms in ischemic stroke: considerations for the development of novel neurotherapeutics.

Candelario-Jalil E.

Curr Opin Investig Drugs. 2009 Jul;10(7):644-54. Review.

PMID:
19579170
8.

Expression patterns of histone deacetylases in experimental stroke and potential targets for neuroprotection.

Chen YT, Zang XF, Pan J, Zhu XL, Chen F, Chen ZB, Xu Y.

Clin Exp Pharmacol Physiol. 2012 Sep;39(9):751-8. doi: 10.1111/j.1440-1681.2012.05729.x.

PMID:
22651689
9.

Acetylation: a lysine modification with neuroprotective effects in ischemic retinal degeneration.

Alsarraf O, Fan J, Dahrouj M, Chou CJ, Menick DR, Crosson CE.

Exp Eye Res. 2014 Oct;127:124-31. doi: 10.1016/j.exer.2014.07.012. Epub 2014 Jul 23.

10.

Human-derived physiological heat shock protein 27 complex protects brain after focal cerebral ischemia in mice.

Teramoto S, Shimura H, Tanaka R, Shimada Y, Miyamoto N, Arai H, Urabe T, Hattori N.

PLoS One. 2013 Jun 13;8(6):e66001. doi: 10.1371/journal.pone.0066001. Print 2013.

13.

Neuroprotective efficacy and therapeutic window of Forsythoside B: in a rat model of cerebral ischemia and reperfusion injury.

Jiang WL, Tian JW, Fu FH, Zhu HB, Hou J.

Eur J Pharmacol. 2010 Aug 25;640(1-3):75-81. doi: 10.1016/j.ejphar.2010.04.055. Epub 2010 May 12.

PMID:
20470770
14.

Phenylbutyrate is a multifaceted drug that exerts neuroprotective effects and reverses the Alzheimer┬┤s disease-like phenotype of a commonly used mouse model.

Cuadrado-Tejedor M, Ricobaraza AL, Torrijo R, Franco R, Garcia-Osta A.

Curr Pharm Des. 2013;19(28):5076-84.

PMID:
23448463
15.

Lutein enhances survival and reduces neuronal damage in a mouse model of ischemic stroke.

Li SY, Yang D, Fu ZJ, Woo T, Wong D, Lo AC.

Neurobiol Dis. 2012 Jan;45(1):624-32. doi: 10.1016/j.nbd.2011.10.008. Epub 2011 Oct 17.

PMID:
22024715
16.

Cerebroprotective effect of Eclipta alba against global model of cerebral ischemia induced oxidative stress in rats.

Mansoorali KP, Prakash T, Kotresha D, Prabhu K, Rama Rao N.

Phytomedicine. 2012 Sep 15;19(12):1108-16. doi: 10.1016/j.phymed.2012.07.004. Epub 2012 Aug 27.

PMID:
22951390
17.

Valproic acid attenuates ischemia-reperfusion injury in the rat brain through inhibition of oxidative stress and inflammation.

Suda S, Katsura K, Kanamaru T, Saito M, Katayama Y.

Eur J Pharmacol. 2013 May 5;707(1-3):26-31. doi: 10.1016/j.ejphar.2013.03.020. Epub 2013 Mar 26.

PMID:
23541723
18.

Pharmacological inhibition of histone deacetylases by suberoylanilide hydroxamic acid specifically alters gene expression and reduces ischemic injury in the mouse brain.

Faraco G, Pancani T, Formentini L, Mascagni P, Fossati G, Leoni F, Moroni F, Chiarugi A.

Mol Pharmacol. 2006 Dec;70(6):1876-84. Epub 2006 Aug 31.

19.

Therapeutic application of histone deacetylase inhibitors for stroke.

Lv L, Tang YP, Han X, Wang X, Dong Q.

Cent Nerv Syst Agents Med Chem. 2011 Jun 1;11(2):138-49. Review.

PMID:
21521169
20.

Protecting neurons.

Ferriero DM.

Epilepsia. 2005;46 Suppl 7:45-51.

Supplemental Content

Support Center